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Abstract
Background: Low carbohydrate diets (LCDs) have been demonstrated to be effective tools for
promoting weight loss and an improved plasma lipid profile. Such diets are often associated with
increased meat consumption, either poultry, fish, and shellfish (PFS), which are generally high in
polyunsaturated fat (PUFA) or red meats (RM), generally high in saturated fat (SFA). The fatty acid
profile and content of a diet may influence the plasma lipid profile of humans. This study examined
whether the type of meat consumed could influence the outcome of an LCD.
Methods: Moderately obese subjects consumed two different LCDs as part of a weight loss
regimen: 1) a diet high in foods of mammalian origin (RM) intended to contain more SFA, or 2) a
diet high in PFS intended to contain more PUFA. Diet dependent changes in body weight,
nutritional intake, and plasma lipids were evaluated during a 28 day study period.
Results: Both diets were associated with significant weight loss after 28 days, -5.26 ± 0.84 kg and
-5.74 ± 0.63 kg for RM and PFS groups, respectively. The PFS diet was associated with a significantly
higher intake of PUFA and cholesterol. Despite high cholesterol and fat intakes, neither diet was
associated with significant changes in plasma cholesterol or the plasma lipoprotein cholesterol
profile. While plasma triglycerides were reduced in both groups, the effect was only statistically
significant for the PFS diet.
Background
Obesity is a primary risk factor for coronary heart disease
(CHD) and mortality [1]. Between 2001 and 2002, 65.7
% of Americans were classified as clinically overweight or
obese [2]. Presently, 29% of men and 24% of women
claim to be attempting to lose weight or maintain previ-
ously achieved weight losses [3]. Orthodox dietary recom-
mendations seek to promote weight loss, weight control
or improved plasma lipid profiles by placing upper limits
on the total intake of sugars, fat, and cholesterol [4,5]. The
American Heart Association, for example, recommends
that persons consume less than 300 mg cholesterol/day
[4]. A fat intake of greater than 35 % of total calories has
been suggested to increase saturated fat intake which, in
theory, also makes avoidance of excess caloric intake dif-
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ficult [5]. The same guidelines suggest maintaining carbo-
hydrate intake between 45 and 65% of total calories [5].
Low carbohydrate diets (LCD) are associated with a fat
intake percentage that typically exceeds orthodox recom-
mendations. LCDs represent a way to reduce caloric
intake, promote weight loss, and reduce the atherogenic-
ity of the plasma lipid profile. The meta-analysis of studies
between January 1, 1980 and February 28, 2005 by Nord-
mann et al [6] demonstrated that relative to low-fat energy
restricted diets, LCDs have a better efficacy for weight loss
promotion and improved plasma lipid profiles than low-
fat diets during the first six months of administration [6].
LCDs have been demonstrated to lead to significant
improvements in the plasma lipid profile and, presuma-
bly, CHD risk [7-10]. The benefits of LCDs on the lipid
profile have been shown to occur independently of weight
loss [9,11].
LCDs are often referred to as 'ketogenic' because of the
accumulation of ketone bodies in the plasma and urine
that is observed when carbohydrate restriction is imposed.
Effective weight loss with a calorie-restricted LCD does
not absolutely require the establishment of ketosis,
although detection of ketosis is often used as a biomarker
for monitoring dietary compliance [12,13].
Increased cholesterol and saturated fatty acid (SFA) intake
has been associated with increased CHD mortality [14]. In
contrast, others have suggested that SFA limitations may
be unwarranted, especially when considered in the con-
text of a LCD [15]. Palmitic acid is a primary dietary SFA
and tends to be hypercholesterolemic [16], though not if
administered in the presence of linolenic acid [17]. Stearic
acid is primarily obtained from beef fat [18] and increased
stearic acid intake actually improves the lipid profile
[16,18]. Diets high in polyunsaturated fatty acids (PUFA)
of marine origin tend to decrease plasma triglycerides,
improve the plasma cholesterol profile, and reduce the
risk of CHD [18-20]. Fish and fish oils are primary sources
of eicosapentaenoic acid and docosahexaenoic acid, the
two primary protective n-3 oils [21]. These associations
lead to the promotion of increased fish consumption as
part of the American Heart Association's dietary recom-
mendations for reducing CHD [4].
The content of SFA and PUFA in different foods varies
greatly [22]. Food products derived from mammals (e.g.
milk, cheese, and meats) tend to contain SFA to PUFA
ratios of 11:1 to 4:1. Food products derived from poultry
(especially eggs), fish (mainly cold water varieties) and
shellfish (including shrimp) tend to have SFA to PUFA
ratios of 3:1 or less. These two different food groupings
have the potential to exert different effects on plasma trig-
lycerides and lipoprotein cholesterol. Previous studies of
the LCD have not compared different types of foods with
different lipid profiles for effects on weight loss and the
plasma lipid profile.
The present study examined the dietary effects of two dif-
ferent diets under free-living conditions encountered by
typical dieters using an LCD. The LCD diets compared in
this study were either high in foods of mammalian origin
(red meats; RM) and presumed to be high in SFA, or high
in poultry, fish, and shellfish (PFS) and presumed to be
high in PUFA.
Methods
Subjects and design
Subjects were recruited for the study following ethical
approval by the Winona State University Human Subjects
Committee. Subjects were self-described as overweight,
non-smokers between the ages of 30 and 50 years who
were not currently taking cholesterol-lowering drugs. Sub-
jects were required to refrain from alcohol for one week
prior to the start of the study (January 10, 2005) and for
the remainder of the 28 days of the study. Subjects were
screened for eligibility by phone and 21 eligible subjects
were invited to attend an orientation session during the
week prior to the study. Eighteen individuals, 6 males and
12 females, participated in the study. The baseline body
mass index of the 12 moderately obese persons who com-
pleted the study was 31.71 ± 0.97 (kg/m2). The primary
motivation for study participation was achievement of
desired weight loss. Subjects received no monetary com-
pensation for their participation.
This study sought to determine the effect of a LCD com-
posed of either RM (red meats or products of mammalian
origin, and presumably containing more SFA) or PFS
(poultry, fish and shellfish, and presumably containing
more PUFA) on weight loss and plasma lipids. The study
attempted to create conditions that would be similar to
those encountered by typical free-living people attempt-
ing to lose weight in a non-clinical atmosphere.
At an orientation session, subjects were familiarized with
the mechanics and goals of a LCD regimen. As a target,
individuals were encouraged to consume a maximum of
20 g of carbohydrates per day that provided 1,487 total
calories (Kcals), with 7 % of calories from carbohydrates,
43% of calories from protein, and 50% from dietary fat
[23]. Subjects were provided with a review outlining
meats deemed as acceptable in a RM (meats or meat prod-
ucts of mammalian origin, excluding those of PFS origin)
or PFS (excluding those of RM origin) LCD diet. Subjects
were instructed to consume on a daily basis not more than
three cups of salad greens or two cups of salad greens and
a cup of cooked low-glycemic index vegetables similar to
those previously described [24]. Subjects were also askedNutrition & Metabolism 2007, 4:23 http://www.nutritionandmetabolism.com/content/4/1/23
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to exclude caffeinated beverages and other sweetened bev-
erages from their diet. Alcohol intake was limited to no
more than one drink per week. Foods high in soy protein
were permitted for either group, although diet records
revealed soy-products were seldom consumed by either
group. Since PFS subjects expressed concern about being
able or willing to avoid cheese (mammalian origin and
high in saturated fat) for 28 days, no more than 3 oz of
cheese per day was permitted for both groups as a way to
improve dietary compliance. However, cow's milk was
not permitted by either group. The subjects were ran-
domly assigned to a LCD high in RM or PFS and for the
following 28 days and the subjects of both groups were
responsible for purchasing, preparing, and consuming the
foods specific to their assigned group. At the instructional
session, subjects were also shown how to maintain a food
journal that would record daily food intake during the
study.
Subjects were contacted by phone or e-mail one to three
times per week in order to answer any questions about
dietary compliance, food journal completion, and to pro-
mote improved dietary compliance. Aerobic exercise was
suggested as a means of promoting maximal weight loss,
but no attempt was made to quantify subject physical
activity during the study.
Following an overnight fast (≥ 9 hours; water only), sub-
jects visited the laboratory between 6:00 and 8:00 AM on
days 0, 7, 14, 21, and 28. During these visits subjects sub-
mitted their food journals, were weighed, and provided
with a new food journal for self-recording of daily food
intake. Journals were used for monitoring dietary compli-
ance and to provide subjects with feedback on what foods
were and were not acceptable. After the interview, urine
samples were collected and analyzed for the presence of
ketones with Bayer Multistix 10 SG reagent strips. Urine
samples were tested immediately to determine if subjects
had reached a ketotic state. The presence of > 5 mg of
ketones/dL was considered positive.
Plasma lipid analysis
Venous blood samples were collected on days 0 and 28
and centrifuged to obtain plasma which was evacuated
with nitrogen gas, flash frozen in liquid nitrogen, and
stored at -80°Celsius until analysis. At the conclusion of
the study, plasma total cholesterol, LDL cholesterol, HDL
cholesterol, and triglyceride concentrations were meas-
ured in duplicate by using a Dade Behring Dimension RxL
clinical chemistry analyzer and direct measurement
(Deerfield, IL). The plasma fatty acid profile of day-28
plasma samples was generated to assess overall dietary
compliance. Plasma was extracted using a modified Folch
wet tissue lipid extraction [25]. Total lipids were esterified
using acetyl chloride/methanol for 1 hour at 80°C [26]. A
temperature-programmed procedure was used [27] and
fatty acids were identified by comparing the retention
time with the GLC 461 standard purchased from Nu-chek-
Prep (Elysian, MN). The fatty acid composition was calcu-
lated using the peak areas on a percentage basis. Eleven
plasma samples (RM = 4; PFS = 7) were found to be suit-
able for plasma fatty acid analysis.
Nutritional analysis
Nutritional content of the two diets was analyzed using
the weekly food diaries and the Interactive Healthy Eating
Index (IHEI) dietary assessment tool [28]. Nutrient intake
profiles for the 28-day study were created for each subject
and the average nutrient intake between day 0 and 28 was
calculated for each subject.
Statistical analysis
Collected data were analyzed by using the Microsoft Excel
data analysis package for descriptive statistics and two-
tailed Student's t-test for comparison between the two
treatment groups (Microsoft Corporation, Redmond,
WA). The Statistical Analysis Software (SAS) Program
(8.0) was used to perform a repeated measures analysis
for evaluating the significance of changes in weight across
time within each group (SAS Institute, Cary, NC). All
descriptive values were expressed as mean ± standard error
of the mean (SEM).
Results
Subject attrition
Of the 18 persons who started the study (RM; n = 9 and
PFS; n = 9), data collected from 12 subjects (RM; n = 5 and
PFS; n = 7) were used in the final analysis. Data were not
used from six subjects: one dropped out voluntarily, one
was dropped when found to have been taking Lipitor for
the control of blood lipids throughout the study, one was
dropped due to taking large dose NSAIDs for an injury,
two were dropped from the study because of gross dietary
non-compliance, and one was dropped for failure to pro-
vide a detailed dietary record.
Effect of diet on weight and ketones
Baseline body mass index (kg/m2) in the RM and PFS
groups was 32.72 ± 1.12 and 30.99 ± 1.50, respectively;
there was no significant difference between the groups.
After consumption of the diets for 28 days, the RM and
PFS group lost -5.26 ± 0.84 kg and -5.74 ± 0.63 kg, respec-
tively (Fig 1). Weight loss was similar and statistically sig-
nificant within both groups across time (p < 0.001), but
there was no significant difference between the groups at
any given time. Urinary ketones were detected at or above
5 mg/dl on 75% of all test times on days 7, 14, 21, and 28
(Table 1).Nutrition & Metabolism 2007, 4:23 http://www.nutritionandmetabolism.com/content/4/1/23
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Effect of diets on nutrient intake
Average carbohydrate intake of the RM and PFS groups
was not significantly different at 61 ± 27 and 50 ± 22 g/
day, respectively. The intake of total calories, protein,
fiber, total fat, SFA, and monounsaturated fat was also not
significantly different between the two groups over the
course of the 28-day study period (Table 2), although SFA
intake did approach statistical significance. However, per-
sons consuming the PFS diet did consume significantly
more PUFA (p = 0.031) and cholesterol (p = 0.036) than
persons consuming the RM diet.
Effect of diets on plasma fatty acids
As a percentage of total plasma fatty acids, the consump-
tion of a RM and PFS diet for 28 days was associated with
differences in the plasma fatty acid profile (Table 3) A sta-
tistically significant difference between the two groups
was observed for docosapenaenoic acid (DPA; p = 0.051).
A near significant difference between groups was observed
for stearic acid (p = 0.071), eicosapentaenoic acid (EPA; p
= 0.170) and docosahexaenoic acid (DHA; p = 0.095). The
average SFA intake for each person during the 28 day
study in the RM and PFS groups was not correlated with
plasma palmitic and stearic acid, expressed as a percentage
of total plasma fatty acids (Figure 2).
Effect of diet on plasma triglycerides and lipoproteins
Consumption of PFS for 28 days was associated with a sig-
nificant (p = 0.042) reduction in plasma triglycerides rel-
ative to day 0 and a non-significant decline in plasma TG
for RM consumers (p = 0.326) (Table 4). The changes in
plasma total, LDL, and HDL cholesterol between day 0
and 28 were non-significant.
Discussion
In this 28-day study of moderately obese persons, both
the RM and PFS LCD effectively promoted significant
weight loss (Table 1). Caloric intake of the two groups dif-
fered by 68 Kcal/day. No significant difference in total
weight loss was observed between the RM and PFS groups,
-5.26 ± 0.84 and -5.74 ± 0.63 kg, respectively. Weight loss
experienced by the RM and PFS groups in the current
study was comparable to that observed on week four of
other previous LCD studies [12,13,29,30].
The carbohydrate intake for both the RM and PFS groups
was 17 ± 3.6 and 18 ± 2.5% of total calories, respectively,
and significantly lower than the current USDA recom-
mendation of 45–65% [5]. The degree of carbohydrate
restriction in the current study was similar to some previ-
ous studies [9,12] but greater than others [7,8,10,13,30]
and greater than the target value of the Atkins induction
phase [24].
Persons consuming the PFS diet had a significantly greater
PUFA intake than those in the RM group (p = 0.036),
although the difference in specific n-3 and n-6 PUFAs for
the diets was not calculated. The SFA intake of the RM
group was slightly elevated, relative to the PFS group. Per-
sons in the RM group had a mean intake of SFA that was
32.42 ± 4.62 g/day and the SFA intake of the PFS group
was 25.12 ± 2.01 g/day, this difference approached signif-
icance (p = 0.137). In interviews with subjects prior to the
start of the study, it was determined that cheese was a
major element that subjects in both the RM and PFS
groups strongly preferred to include in their diets. The
investigators chose to permit controlled and documented
cheese consumption in the PFS group in order to improve
honest dietary reporting and compliance. In light of the
high SFA content of cheese, it was not surprising that the
Body weight changes relative to starting weight during the  consumption of a low-carbohydrate diets high in either red  meat (RM) or poultry/fish/shellfish (PFS) for 28 days Figure 1
Body weight changes relative to starting weight during the 
consumption of a low-carbohydrate diets high in either red 
meat (RM) or poultry/fish/shellfish (PFS) for 28 days. No sig-
nificant differences between groups were observed at any 
given week, but there was a statistically significant effect by 
time P < 0.001.
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Table 1: Absence or presence of urinary ketones (above 5 mg/dl) in urine samples for subjects consuming a low-carbohydrate diet for 
28 day1
Treatment Ketones Day 0 Day 7 Day 14 Day 21 Day 28
R M A b s e n t 51111
P r e s e n t 04444
P F S A b s e n t 72222
P r e s e n t 05555
1Mean ± SEM; RM, red meat (n = 5); PFS, poultry/fish/shellfish (n = 7)Nutrition & Metabolism 2007, 4:23 http://www.nutritionandmetabolism.com/content/4/1/23
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difference between the two groups for SFA intake only
approached significance.
The day 28 plasma fatty acid profile of EPA, DHA, and
DPA suggests that the RM and PFS groups were compliant
with regards to consuming their assigned diets (Table 3).
Two specific PUFAs that are indicative of PFS consump-
tion are the n-3 marine oils EPA and DHA [21,31]. Plasma
fatty acid levels of EPA and DHA in the PFS group were
both greater than that observed in the RM group. The dif-
ferences approached significance with p-values of 0.170
and 0.095 for EPA and DHA, respectively. Subjects con-
suming the RM diet, which typically contained beef prod-
ucts, would be expected to consume more of the non-
marine n-3 fatty acid DPA [32] and stearic acid [16,18].
The group-specific difference for DPA was significant (p =
0.051) and approached significance for stearic acid (p =
0.071). Figure 2 demonstrates that within the RM and PFS
groups, when expressed as a percentage of the total,
plasma palmitic or stearic acid was not tightly correlated
with total SFA intake, suggesting that the control of the
plasma levels of these two fatty acids is under predomi-
nately metabolic, not dietary control.
The PFS diet resulted in the consumption of nearly twice
the cholesterol (630 ± 95 mg/day) as members of the RM
group (333 ± 39 mg/day). This high cholesterol intake
was mostly attributable to shrimp and eggs consumed on
Table 3: Plasma fatty acid profile (percentage of total) following the consumption of a low-carbohydrate diet for 28 days1
Percent of Total Fatty Acids
RM PFS
Myristic (C14:0) 0.55 ± 0.03 0.74 ± 0.13
Palmitic (C16:0) 23.92 ± 0.38 24.95 ± 0.67
Palmitoleic (C16:1) 1.35 ± 0.15 1.35 ± 0.11
Stearic (C18:0) 7.63 ± 0.522 6.65 ± 0.26
Oleic (C:18:1; n9) 19.83 ± 1.19 20.60 ± 1.75
Linoleic (C18:2; n6) 32.32 ± 1.73 31.80 ± 2.09
Linolenic (C18:3; n6) 0.83 ± 0.50 0.40 ± 0.04
Behenic (C22:0) 0.42 ± 0.22 0.33 ± 0.11
Homogamma Linolenic (C20:3; n6) 0.81 ± 0.25 0.70 ± 0.05
Arachidonic (C20:4; n6) 10.30 ± 1.52 10.15 ± 0.72
Eicosapentaenoic (C20:5; n3) 0.34 ± 0.063 0.57 ± 0.11
Docosapentaenoic (C22:5; n3) 0.48 ± 0.084 0.31 ± 0.01
Docosahexaenoic (C22:6; n3) 1.29 ± 0.185 1.71 ± 0.13
Total n3 2.11 ± 0.31 2.49 ± 0.26
Total n6 44.27 ± 1.01 43.05 ± 1.89
1RM, Red meat (RM; n = 5); Poultry/fish/shellfish (PFS; n = 7) Carbohydrates (Carb); Cholesterol (Chol); Saturated fat (SFA); Polyunsaturated fat 
(PUFA); Monounsaturated fat. Data expressed as mean ± SEM;
2Statistically significant difference between treatments (p = 0.031)
3Approached statistically significant difference between treatments (p = 0.138)
4Statistically significant difference between treatments (p = 0.036)
Table 2: Average nutrient intake during the consumption of low-carbohydrate diets high in red meat or poultry/fish and shellfish for 28 
days1
Diet Type Carb (g/day) Carb (% cal) Protein (g/day) Protein (% cal) Total Fat (g/day) Total Fat (% cal)
RM 62 ± 28 17 ± 3.6 106 ± 9 31 ± 1.7 82 ± 10 52 ± 2.7
PFS 50 ± 22 18 ± 2.5 101 ± 5 30 ± 1.0 77 ± 3.7 52 ± 2.4
Total Calories Chol (mg/day) SFA (g/day) PUFA (g/day) MUFA (g/day) Fiber (g/day)
RM 1410 ± 155 333 ± 392 32 ± 53 9.8 ± 2.04 32 ± 4 6.4 ± 1.0
PFS 1342 ± 30 630 ± 95 25 ± 2.0 16 ± 1.5 30 ± 1.8 6.5 ± 0.8
1RM, Red meat (RM; n = 5); Poultry/fish/shellfish (PFS; n = 7) Carbohydrates (Carb); Cholesterol (Chol); Saturated fat (SFA); Polyunsaturated fat 
(PUFA); Monounsaturated fat. Data expressed as mean ± SEM;
2Statistically significant difference between treatments (p = 0.031)
3Approached statistically significant difference between treatments (p = 0.138)
4Statistically significant difference between treatments (p = 0.036)Nutrition & Metabolism 2007, 4:23 http://www.nutritionandmetabolism.com/content/4/1/23
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25 and 88% of all days, respectively. Subjects made these
cholesterol-rich foods a staple of their self-purchased free-
living diets because of taste preferences, familiarity, and
product availability. Studies of human egg and shellfish
consumption have suggested that cholesterol content has,
at best, only a small impact on the plasma cholesterol pro-
file [33-35]. Consumption of large amounts of choles-
terol-rich eggs and shrimp by PFS subjects may have
influenced the expected improvements in the plasma lipid
profile that would be expected to accompany the observed
weight loss [9,36]. The moderate degree of carbohydrate
restriction observed in the current study may have been
inadequate to produce the LCD induced changes in the
plasma cholesterol profile associated with the previously
described studies.
Subjects experienced a significant reduction in plasma
triglycerides in the PFS group (p = 0.042) while plasma
triglyceride reduction in the RM group was not significant
(p = 0.326). Because the RM subjects began the study with
a plasma TG concentration that was generally lower than
that of the PFS group they may have been less responsive
to diet induced reductions in plasma triglycerides.
The total daily fiber intake recommendation of the Food
and Nutrition Board is 38 and 25 g/day for men and
women [37]. In the current study, fiber intake for RM and
PFS subjects was 6.4 ± 1.1 and 6.5 ± 0.8 g fiber/day,
respectively. It has been previously demonstrated that
increased fiber intake as part of a LCD may improve
potential reductions in LDL cholesterol, though it is not
required for improvements in the plasma lipid profile
[10].
Conclusion
This study determined that a 28 day LCD high in RM or
PFS promotes a similar significant degree of weight loss.
In spite of orthodox concerns about the impact of dietary
cholesterol and saturated fat, no significant deleterious
changes were observed to result from adherence to either
Table 4: Change in the plasma triglyceride and lipoprotein concentration following the consumption of a low-carbohydrate diet for 28 
days1
Day Triglycerides (mmol/L) Total Cholesterol (mmol/L) LDL Cholesterol (mmol/L) HDL Cholesterol (mmol/L)
RM-0 1.04 ± 0.17 4.78 ± 0.35 2.84 ± 0.26 1.50 ± 0.13
RM-28 0.83 ± 0.11 4.47 ± 0.34 2.79 ± 0.22 1.31 ± 0.12
RM-Change -0.21 ± 0.19 -0.30 ± 0.15 -0.05 ± 0.14 -0.19 ± 0.05
PFS-0 1.27 ± 0.13 5.10 ± 0.31 3.18 ± 0.35 1.30 ± 0.14
PFS-28 0.87 ± 0.082 4.95 ± 0.31 3.33 ± 0.27 1.13 ± 0.10
PFS-Change -0.39 ± 0.10 -0.15 ± 0.23 0.15 ± 0.21 -0.17 ± 0.08
1RM, red meat; PFS, poultry/fish/shellfish; Mean ± SEM
2Statistically significant difference for triglycerides within PFS treatment between day 0 and 28 (p = 0.042)
Plasma levels of palmitic and stearic acid were not correlated with saturated fat intake as part of a 28 day low carbohydrate  diet rich in red meat (RM) or poultry/fish/shellfish (PFS) Figure 2
Plasma levels of palmitic and stearic acid were not correlated with saturated fat intake as part of a 28 day low carbohydrate 
diet rich in red meat (RM) or poultry/fish/shellfish (PFS).Nutrition & Metabolism 2007, 4:23 http://www.nutritionandmetabolism.com/content/4/1/23
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the RM or PFS diets, which were both high in total choles-
terol and total fat. This study suggests that dire predictions
about LCD effects are anachronistic.
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